GATC Health

The AI engine Fit Assessment

Beta

GATC Health effectively leverages machine learning to discover health patterns and expand therapeutics, while also utilizing its platform for potential drug repurposing.

Blurb

AI platform transforming drug discovery & development.

HQ Location

United States

Founded

2020

Employees

11 - 50

Total funding raised

$5.41M

Last Funding Event

Seed, $240.00K, August 23, 2023

Smart insights

  • Catherine Msc (Chief People Officer) worked at Lilium as Head of People Business Partnering for 1.5 years (2021 - 2022)
  • Val Miftakhov (Founder & CEO) worked at Google in various roles, including Head of R&D, Google for Work Incubation, for a total of 4 years (2012 - 2016)
  • 6m headcount growth: 25%
  • 1Y headcount growth: 94%
  • Headcount-to-last-round ratio: 5.3 employees/$M
Subspaces
  • Drug Repurposing

Developer of a multi-omic advanced technology platform designed to provide insight into individualized, specific health risks. The company's platform offers personalized medical analysis and reporting for disease risk, tolerance, complications, and prevention, pre-screening clinical trial participants for predictive and medical professionals with individualized multi-omic data analyses outcomes and anomalies and whole-genome analysis, enabling individuals, clinicians, and corporations to greatly reduce or mitigate health and reduces the risk, time and costs for life sciences companies.